74164EGP
- Active ingredient
- apalutamide
- Strength
- 60 mg
- Form
- tablet
- Manufacturer
- janssen cilag > soficopharm
- Route
- oral.solid
Uses
Used in specific forms of prostate cancer, including non-metastatic and metastatic castration-sensitive disease.
Do not use if
Hypersensitivity to apalutamide or formulation components.
Side effects
Fatigue, rash, hypertension, falls, fractures, and hot flushes may occur.
Warnings
Requires specialist supervision. Monitor for cardiovascular, skeletal, and neurological adverse effects.
How it works
Apalutamide is a nonsteroidal androgen receptor inhibitor that blocks androgen signaling in prostate cancer cells.
Storage
Store at room temperature in the original container.
